Home/Filings/4/0001457612-18-000114
4//SEC Filing

Carroll Pamela 4

Accession 0001457612-18-000114

CIK 0001457612other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 8:31 PM ET

Size

5.6 KB

Accession

0001457612-18-000114

Insider Transaction Report

Form 4
Period: 2018-11-06
Carroll Pamela
SVP IMMUNO-ONCOLOGY
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-11-06+75,00075,000 total
    Exercise: $0.73Exp: 2028-11-06Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest as to 1/4th of the shares subject to the option on the first anniversary of the Grant Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of November 6, 2019 (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest).

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeother

Related Parties

1
  • filerCIK 0001755969

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:31 PM ET
Size
5.6 KB